EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
×
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
NASDAQ:CNTG

Centogene - CNTG Stock Forecast, Price & News

$0.80
+0.04 (+5.26%)
(As of 11/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.76
$0.85
50-Day Range
$0.73
$1.37
52-Week Range
$0.68
$7.37
Volume
57,397 shs
Average Volume
15,672 shs
Market Capitalization
$21.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.50

Centogene MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
431.3% Upside
$4.25 Price Target
Short Interest
Healthy
0.53% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.06
Upright™ Environmental Score
News Sentiment
0.51mentions of Centogene in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.68) to ($1.35) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.51 out of 5 stars

Medical Sector

183rd out of 1,038 stocks

Medical Laboratories Industry

8th out of 25 stocks

CNTG stock logo

About Centogene (NASDAQ:CNTG) Stock

Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including PCR and antigen testing services. It has collaboration and license agreements with Shire International GmbH, Pfizer Inc., Dr. Bauer Laboratoriums GmbH, Fraport AG, Takeda Pharmaceutical Company Limited, and Twist Bioscience Corporation. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

Receive CNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centogene and its competitors with MarketBeat's FREE daily newsletter.

CNTG Stock News Headlines

Centogene B V (CNTG)
See More Headlines
Receive CNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centogene and its competitors with MarketBeat's FREE daily newsletter.

CNTG Company Calendar

Last Earnings
11/24/2021
Today
11/29/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CNTG
Fax
N/A
Employees
660
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.25
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$2.50
Forecasted Upside/Downside
+837.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
3 Analysts

Profitability

Net Income
$-55,430,000.00
Pretax Margin
-39.06%

Debt

Sales & Book Value

Annual Sales
$224.71 million
Book Value
$3.78 per share

Miscellaneous

Free Float
N/A
Market Cap
$21.67 million
Optionable
Not Optionable
Beta
-0.95

Key Executives

  • Dr. Andrin Oswald M.D. (Age 50)
    Ph.D., Advisor
    Comp: $439.82k
  • Ms. Kim Stratton (Age 60)
    CEO & Member of Management Board
  • Mr. Jose Miguel Coego Rios
    Chief Financial Officer
  • Dr. Patrice P. Denefle Ph.D. (Age 62)
    Chief Scientific Officer
  • Mr. Florian Vogel Ph.D. (Age 41)
    Chief Process Officer
  • Dr. Peter Bauer M.D. (Age 52)
    Chief Genomic Officer
  • Mr. Lennart M. Streibel
    Director of Corp. Projects













CNTG Stock - Frequently Asked Questions

Should I buy or sell Centogene stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centogene in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CNTG shares.
View CNTG analyst ratings
or view top-rated stocks.

What is Centogene's stock price forecast for 2023?

3 equities research analysts have issued 1-year price targets for Centogene's stock. Their CNTG share price forecasts range from $2.50 to $6.00. On average, they anticipate the company's stock price to reach $4.25 in the next twelve months. This suggests a possible upside of 418.3% from the stock's current price.
View analysts price targets for CNTG
or view top-rated stocks among Wall Street analysts.

How have CNTG shares performed in 2022?

Centogene's stock was trading at $5.2283 at the beginning of 2022. Since then, CNTG stock has decreased by 84.3% and is now trading at $0.82.
View the best growth stocks for 2022 here
.

Are investors shorting Centogene?

Centogene saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 32,500 shares, an increase of 19.0% from the October 31st total of 27,300 shares. Based on an average trading volume of 16,800 shares, the days-to-cover ratio is presently 1.9 days. Currently, 0.5% of the company's shares are short sold.
View Centogene's Short Interest
.

How were Centogene's earnings last quarter?

Centogene (NASDAQ:CNTG) posted its quarterly earnings results on Wednesday, November, 24th. The company reported ($1.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.59) by $0.49. The firm had revenue of $35.60 million for the quarter, compared to analyst estimates of $31.91 million. Centogene had a negative net margin of 35.35% and a negative trailing twelve-month return on equity of 134.55%. During the same period in the prior year, the business posted ($0.32) earnings per share.

What other stocks do shareholders of Centogene own?
When did Centogene IPO?

(CNTG) raised $60 million in an IPO on Thursday, November 7th 2019. The company issued 4,000,000 shares at $14.00-$16.00 per share. SVB Leerink and Evercore ISI acted as the underwriters for the IPO and Baird and BTIG were co-managers.

What is Centogene's stock symbol?

Centogene trades on the NASDAQ under the ticker symbol "CNTG."

Who are Centogene's major shareholders?

Centogene's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Platinum Investment Management Ltd. (8.78%).

How do I buy shares of Centogene?

Shares of CNTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Centogene's stock price today?

One share of CNTG stock can currently be purchased for approximately $0.82.

How much money does Centogene make?

Centogene (NASDAQ:CNTG) has a market capitalization of $22.21 million and generates $224.71 million in revenue each year. The company earns $-55,430,000.00 in net income (profit) each year or ($2.42) on an earnings per share basis.

How many employees does Centogene have?

The company employs 660 workers across the globe.

How can I contact Centogene?

Centogene's mailing address is AM STRANDE 7, ROSTOCK 2M, 18055. The official website for the company is www.centogene.com. The company can be reached via phone at 38180113500 or via email at investor.relations@centogene.com.

This page (NASDAQ:CNTG) was last updated on 11/29/2022 by MarketBeat.com Staff